SVETLANA VARCHENKO: Open Payments
NPI 1639652100 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,334 in 73 payments from 24 companies in 2025. Trend: 2023 $1,006 · 2024 $1,656 · 2025 $1,334
Food & beverage: $1,334
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $182 |
| Lilly USA, LLC | 14 | $171 |
| Novo Nordisk Inc | 6 | $102 |
| GlaxoSmithKline, LLC. | 6 | $95 |
| PFIZER INC. | 4 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $84 |
| Axsome Therapeutics, Inc. | 4 | $71 |
| Astellas Pharma US Inc | 2 | $65 |
| Corium, LLC | 3 | $64 |
| Phathom Pharmaceuticals, Inc. | 3 | $59 |
Products named: VRAYLAR, JARDIANCE, TRELEGY ELLIPTA, MOUNJARO, NURTEC ODT, CAPLYTA, Auvelity, Veozah.
Industry payments across IN — which companies pay providers there.
